Praxis reports positive seizure reduction results from vormatrigine trial

Go back to Praxis reports positive seizure reduction results from vormatrigine trial
(NASDAQ: PRAX) Delayed: 351.81 --0 (-0%)
Previous Close $351.81    52 Week High
Open $351.81    52 Week Low
Day High $351.81    P/E N/A 
Day Low $351.81    EPS
Volume 1,120